Nomura S, Katoh H, Yanagisawa S, Noguchi T, Okada K, Watanabe M (2023) Administration of the GLP-1 receptor agonist exenatide in rats improves functional recovery after spinal cord injury by reducing endoplasmic reticulum stress
Exploring the therapeutic potential of bioactive compounds from plant sources
A study by Seiwerth et al
Although a large number of short-term and medium-term clinical studies support the safety and efficacy of GLP-1RAs, there are insufficient data on the presence of delayed side effects with their long-term (decades) use (Guirguis et al., 2024)
Proper institutional oversight, safety protocols, and regulatory compliance are required
BB: Resources, Writing review & editing, Writing original draft